Impact of a cancer clinical trials web site on discussions about trial participation: A cluster randomized trial

Publication Type:
Journal Article
Citation:
Annals of Oncology, 2012, 23 (7), pp. 1912 - 1918
Issue Date:
2012-07-01
Metrics:
Full metadata record
Files in This Item:
Filename Description Size
mdr585.pdfPublished Version147.19 kB
Adobe PDF
Background: Cancer patients want access to reliable information about currently recruiting clinical trials. Patients and methods: Oncologists and their patients were randomly assigned to access a consumer-friendly cancer clinical trials web site [Australian Cancer Trials (ACT), . www.australiancancertrials.gov.au] or to usual care in a cluster randomized controlled trial. The primary outcome, measured from audio recordings of oncologist-patient consultations, was the proportion of patients with whom participation in any clinical trial was discussed. Analysis was by intention-to-treat accounting for clustering and stratification. Results: Thirty medical oncologists and 493 patients were recruited. Overall, 46% of consultations in the intervention group compared with 34% in the control group contained a discussion about clinical trials (P = 0.08). The mean consultation length in both groups was 29 min (P = 0.69). The proportion consenting to a trial was 10% in both groups (P = 0.65). Patients' knowledge about randomized trials was lower in the intervention than the control group (mean score 3.0 versus 3.3, P = 0.03) but decisional conflict scores were similar (mean score 42 versus 43, P = 0.83). Conclusions: Good communication between patients and physicians is essential. Within this context, a web site such as Australian Cancer Trials may be an important tool to encourage discussion about clinical trial participation. © The Author 2012. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved.
Please use this identifier to cite or link to this item: